136 related articles for article (PubMed ID: 1682465)
1. Cardiovascular effects of intracerebroventricular injections of (+/-)-nebivolol and its enantiomers--a comparison with those of metoprolol in the rat.
Midol-Monnet M; Davy M; Heimburger M; Beslot F; Cohen Y
J Pharm Pharmacol; 1991 Jul; 43(7):504-9. PubMed ID: 1682465
[TBL] [Abstract][Full Text] [Related]
2. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of nebivolol.
Janssens WJ
J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
[TBL] [Abstract][Full Text] [Related]
4. Influence of nebivolol on the cardiovascular hemodynamics during postural changes and isometric exercise.
Duprez D; Lefebvre R; De Backer T; De Sutter P; Trouerbach J; Clement DL
Cardiovasc Drugs Ther; 1991 Aug; 5(4):709-17. PubMed ID: 1679662
[TBL] [Abstract][Full Text] [Related]
5. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
[TBL] [Abstract][Full Text] [Related]
6. Effects of the selective beta 1-adrenoceptor antagonist, nebivolol, on cardiovascular parameters in the pithed normotensive rat.
Schneider J; Fruh C; Wilffert B; Peters T
Pharmacology; 1990; 40(1):33-41. PubMed ID: 1970437
[TBL] [Abstract][Full Text] [Related]
7. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
Ignarro LJ
Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
[TBL] [Abstract][Full Text] [Related]
8. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension].
Gromnatskiĭ NI; Dius'mikeeva NB
Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053
[TBL] [Abstract][Full Text] [Related]
9. Lack of inverse agonistic activity of nebivolol, its D- and L-enantiomers and of in vivo metabolized nebivolol in human myocardium.
Bundkirchen A; Nguyen Q; Brixius K; Bölck B; Mehlhorn U; Schwinger RH
Eur J Pharmacol; 2003 Aug; 476(1-2):97-105. PubMed ID: 12969754
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage.
Ozakca I; Arioglu-Inan E; Esfahani H; Altan VM; Balligand JL; Kayki-Mutlu G; Ozcelikay AT
Am J Physiol Heart Circ Physiol; 2013 May; 304(9):H1267-76. PubMed ID: 23457011
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor-mediated cAMP accumulation in cardiac cells: effects of nebivolol.
Pauwels PJ; Leysen JE; Janssen PA
Eur J Pharmacol; 1989 Dec; 172(6):471-9. PubMed ID: 2575531
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of dl-nebivolol and its enantiomers--a comparison with those of atenolol.
Van de Water A; Xhonneux R; Reneman RS; Janssen PA
Eur J Pharmacol; 1988 Oct; 156(1):95-103. PubMed ID: 3208842
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
[TBL] [Abstract][Full Text] [Related]
14. The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer.
Xhonneux R; Wouters L; Reneman RS; Janssen PA
Eur J Pharmacol; 1990 Jun; 181(3):261-5. PubMed ID: 1974517
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats.
Bertera FM; Del Mauro JS; Lovera V; Chiappetta D; Polizio AH; Taira CA; Höcht C
Hypertens Res; 2014 Mar; 37(3):194-201. PubMed ID: 24132009
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the sympatholytic action of nebivolol and hypotension.
Ward JE; Coles P; Cox H; Eisenhofer G; Angus JA
J Cardiovasc Pharmacol; 1992 Jul; 20(1):115-24. PubMed ID: 1383620
[TBL] [Abstract][Full Text] [Related]
17. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure.
Eeftinck Schattenkerk DW; van den Bogaard B; Cammenga M; Westerhof BE; Stroes ES; van den Born BJ
J Hypertens; 2013 Dec; 31(12):2447-54. PubMed ID: 24126713
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome.
Ayers K; Byrne LM; DeMatteo A; Brown NJ
Hypertension; 2012 Apr; 59(4):893-8. PubMed ID: 22353614
[TBL] [Abstract][Full Text] [Related]
19. Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats.
Bertera FM; Del Mauro JS; Polizio AH; Chiappetta D; Taira CA; Höcht C
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):833-43. PubMed ID: 22566167
[TBL] [Abstract][Full Text] [Related]
20. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]